AJ Lanigan: Yes. Actually, Pharma firms are generating huge funds with remedies like Keytruda and Opdivo that offer with PD-1 and PD-L1. Here’s the super awesome component: consider checkpoints as targeted visitors alerts. You don’t want an immune program that’s managing wild like a freight teach more than a cliff. waiting for link from Social Bookmarking (2)